Skip to content
Open access

Multi-Omics Integration of Transcriptomics and Metabolomics with Machine Learning Uncovers Novel Risk Factors for Alzheimer’s disease

Sep 2026 · Journal of Alzheimer's Disease · Vol 114, pp. 481 - 492 · 0 citations · 67 references
Medicine

TL;DR

Multi-omics integration identified candidate biomarkers reflecting inflammatory signaling, mitochondrial dysfunction, and lipid metabolism reflecting inflammatory signaling, mitochondrial dysfunction, and lipid metabolism as well as influential genes and metabolites associated with cognition in Alzheimer's disease.

Abstract

Background Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive decline, memory impairment, and functional deterioration. Its complex pathogenesis involves amyloid plaques, tau tangles, neuroinflammation, synaptic dysfunction, and interacting genetic, environmental, and lifestyle factors. Transcriptomic and metabolomic studies have revealed molecular disruptions relevant to AD, supporting integrative approaches for biomarker discovery. Objective To integrate genetically imputed whole-blood transcriptomics and measured plasma metabolomics to predict cognitive performance, assessed using the PACC3 score, and identify influential genes and metabolites associated with cognition. Methods A machine learning model integrated transcriptomic and metabolomic data from 1046 participants in the Wisconsin Registry for Alzheimer's Prevention (WRAP). Performance was evaluated in a WRAP holdout test set and independently validated in 85 participants from the Wisconsin Alzheimer's Disease Research Center (ADRC). Feature importance was used to identify molecular contributors to prediction. Results The model achieved a normalized root mean squared error of 0.707 and an R2 of 0.338 in the WRAP holdout dataset (p = 5.93 × 10−30), and corresponding values of 0.915 and 0.061 in ADRC (p = 4.71 × 10−2). Higher imputed expression of RIPK1, IL6ST, and BIN1 was associated with poorer cognitive performance, whereas UGP2, NDUFB5, and TMOD2 were associated with better performance. Predictive metabolites included benzoate, 3-phenylpropionate, imidazolelactate, hexanoylcarnitine, and propionate-related metabolites. Conclusions Multi-omics integration identified candidate biomarkers reflecting inflammatory signaling, mitochondrial dysfunction, and lipid metabolism. Together, these findings demonstrate complementary biological information captured across both omics layers. These convergent signals support improved molecular characterization of AD and biomarker prioritization for future mechanistic and translational studies.

Read PDF

Similar papers

Open access Sep 2026

An Integrated Analysis of Manganese Metabolism‐Related Genes and Their Association With Biomarkers, Immune Infiltration, and Clinical Subtypes in Alzheimer's Disease

Alzheimer's disease (AD), a neurodegenerative condition marked by amyloid‐beta plaques and tau protein neurofibrillary tangles, progresses against a backdrop of essential biological processes. Manganese, an indispensable trace element for vital functions including energy metabolism and antioxidant defense, is integral...

Sheng-Nan Shu, Jia-Hao Hu, Shan-Shan Hu et al. · 0 citations
Open access Oct 2026

HINN prioritizes multi-omics biomarkers associated with cognitive decline

Abstract Motivation Integrating multi-omics data for disease prediction remains challenging due to the complexity of cross-layer biological interactions and the limited use of prior biological knowledge in many machine learning models. We present the Hierarchical Input Neural Network (HINN), a deep learning framework t...

Yashu Vashishath, S. Beaver, Fahad Saeed et al. · 0 citations
Sep 2026

Integrating transcriptomic data to identify calmodulin-related diagnostic biomarkers for Alzheimer's disease

Background Alzheimer's disease (AD) is driven by amyloid-β, tau protein, and neuroinflammation. Calmodulin-mediated calcium signaling centrally links synaptic dysfunction, tauopathy, and inflammation, making it a key mechanistic and therapeutic target. Objective To identify calmodulin-related diagnostic biomarkers for...

Xi'an Wang, Yan-Bin Huang, Jiu-Ru Li · 0 citations
Open access Sep 2026

Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study

This exploratory study integrates pilot-scale metabolomics with genetic analyses to identify candidate metabolic signals and inflammatory pathways linked to PD and indicated that SULT1A1 may partially mediate the association between 3-phenylpropionylglycine and PD.

Yue Lang, Hui Zhang, Rui Feng et al. · 0 citations
Oct 2026

A five-gene mitochondrial-lipid metabolism signature for Alzheimer's disease diagnosis identified by machine learning and validated in independent cohorts.

BackgroundMitochondrial dysfunction and lipid metabolism dysregulation represent early key events in Alzheimer's disease (AD), yet integrated transcriptomic signatures combining these two biological processes for AD diagnosis remain poorly defined.ObjectiveThis study aimed to construct and validate a mitochondrial-lipi...

Bo Liu, Jing-Jing Wu, Jun Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.